美第奇新星生物技术(MNOV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MNOV 美第奇新星生物技术

盘后交易 02-13 18:39:41 EST

1.48

-0.08

-5.13%

盘后1.48

+0.000.00%

17:40 EST

最高1.58	最低1.47	成交量5.88万
今开1.54	昨收1.56	日振幅7.05%
总市值7,274万	流通市值6,228万	总股本4,915万
成交额8.98万	换手率0.14%	流通股本4,208万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MNOV","market":"US","secType":"STK","nameCN":"美第奇新星生物技术","latestPrice":1.48,"timestamp":1771016400000,"preClose":1.56,"halted":0,"volume":58761,"hourTrading":{"tag":"盘后","latestPrice":1.48,"preClose":1.48,"latestTime":"17:40 EST","volume":61,"amount":90.28,"timestamp":1771022443694,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.05128205128205133,"floatShares":42080953,"shares":49146246,"eps":-0.244877,"marketStatus":"盘后交易","change":-0.08,"latestTime":"02-13 18:39:41 EST","open":1.54,"high":1.58,"low":1.47,"amount":89785.04517,"amplitude":0.070513,"askPrice":1.62,"askSize":126,"bidPrice":1.35,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.244877,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1771030800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1165467600000,"exchange":"NASDAQ","adjPreClose":1.56,"postHourTrading":{"tag":"盘后","latestPrice":1.48,"preClose":1.48,"latestTime":"17:40 EST","volume":61,"amount":90.28,"timestamp":1771022443694,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.372523,"impliedVol":1.3418,"impliedVolPercentile":0.2789},"requestUrl":"/m/hq/s/MNOV","defaultTab":"news","newsList":[{"id":"1126687267","title":"美第奇新星生物技术宣布：Seanobi研究扩展准入项目已成功入组100名ALS患者，评估MN-166（异丁司特）疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1126687267","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126687267?lang=zh_cn&edition=full","pubTime":"2026-01-30 07:00","pubTimestamp":1769727623,"startTime":"0","endTime":"0","summary":"美第奇新星生物技术（MediciNova）近日公布重要研究进展，其针对肌萎缩侧索硬化症（ALS）患者的Seanobi研究扩展准入项目（EAP）已成功完成100名患者的入组工作。该项目旨在深入评估其核心候选药物MN-166（Ibudilast，异丁司特）在该患者群体中的潜力。\n这一里程碑标志着项目推进顺利，为更多ALS患者提供了接触该研究性疗法的机会。研究团队将继续收集数据，以进一步了解MN-166的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MNOV"],"gpt_icon":0},{"id":"1170552627","title":"美第奇新星生物技术宣布完成患者招募，以评估Mn-166（伊布利斯特）在预防化疗诱导的周围神经病中的效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1170552627","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170552627?lang=zh_cn&edition=full","pubTime":"2025-12-18 19:03","pubTimestamp":1766055818,"startTime":"0","endTime":"0","summary":"美第奇新星生物技术宣布完成患者招募，以评估Mn-166（伊布利斯特）在预防化疗诱导的周围神经病中的效果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MNOV"],"gpt_icon":0},{"id":"1185435077","title":"美第奇新星生物技术公布关于Mn-166（伊布地拉斯特）在ALS（Combat-ALS临床试验）中进行的2/3期临床试验随机患者基本特征的最新信息，发表在第36届国际ALS/MND研讨会上","url":"https://stock-news.laohu8.com/highlight/detail?id=1185435077","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185435077?lang=zh_cn&edition=full","pubTime":"2025-12-08 19:02","pubTimestamp":1765191734,"startTime":"0","endTime":"0","summary":"美第奇新星生物技术公布关于Mn-166（伊布地拉斯特）在ALS（Combat-ALS临床试验）中进行的2/3期临床试验随机患者基本特征的最新信息，发表在第36届国际ALS/MND研讨会上。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MNOV"],"gpt_icon":0},{"id":"1101044379","title":"美第奇新星生物技术在2025年生物技术突破奖中获合同研究与开发创新奖","url":"https://stock-news.laohu8.com/highlight/detail?id=1101044379","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101044379?lang=zh_cn&edition=full","pubTime":"2025-11-07 07:00","pubTimestamp":1762470020,"startTime":"0","endTime":"0","summary":"美第奇新星生物技术在2025年生物技术突破奖中获合同研究与开发创新奖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNOV","BK4139"],"gpt_icon":0},{"id":"1130040429","title":"美第奇新星生物技术宣布Mn-001 (Tipelukast)的Mn-001-Natg-202临床试验完成患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1130040429","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130040429?lang=zh_cn&edition=full","pubTime":"2025-11-04 20:00","pubTimestamp":1762257635,"startTime":"0","endTime":"0","summary":"美第奇新星生物技术宣布Mn-001 (Tipelukast)的Mn-001-Natg-202临床试验完成患者招募。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNOV","BK4139"],"gpt_icon":0},{"id":"2580407844","title":"美第奇新星生物技术股价上涨12.61% 市值涨828.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580407844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580407844?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:31","pubTimestamp":1761917473,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日21时31分，美第奇新星生物技术股票出现波动，股价快速拉升12.61%。截至发稿，该股报1.34美元/股，成交量1251.9万股，换手率25.52%，振幅5.04%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。美第奇新星生物技术股票所在的生物技术行业中，整体跌幅为0.28%。美第奇新星生物技术公司简介：MediciNova Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031213113a4801ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031213113a4801ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNOV"],"gpt_icon":0},{"id":"1171429926","title":"MediciNova宣布完成Mn-166（伊布地拉司特）Combat-ALS 2B/3期临床试验的患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1171429926","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171429926?lang=zh_cn&edition=full","pubTime":"2025-09-22 20:00","pubTimestamp":1758542423,"startTime":"0","endTime":"0","summary":"MediciNova宣布完成Mn-166（伊布地拉司特）Combat-ALS 2B/3期临床试验的患者入组","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNOV","BK4139"],"gpt_icon":0},{"id":"1178701907","title":"MediciNova宣布将在第36届国际ALS/MND研讨会上发表Combat-ALS临床试验海报","url":"https://stock-news.laohu8.com/highlight/detail?id=1178701907","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178701907?lang=zh_cn&edition=full","pubTime":"2025-09-16 20:02","pubTimestamp":1758024121,"startTime":"0","endTime":"0","summary":"MediciNova宣布将在第36届国际ALS/MND研讨会上发表Combat-ALS临床试验海报展示。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNOV","BK4139"],"gpt_icon":0},{"id":"1177552080","title":"MediciNova提交招股说明书，涉及Ya Ii Pn, Ltd出售最多2500万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1177552080","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177552080?lang=zh_cn&edition=full","pubTime":"2025-08-23 04:25","pubTimestamp":1755894313,"startTime":"0","endTime":"0","summary":"MediciNova提交招股说明书，涉及Ya Ii Pn, Ltd出售最多2500万股普通股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNOV","BK4139"],"gpt_icon":0},{"id":"2557365023","title":"美第奇新星生物技术盘中异动 快速下挫5.24%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557365023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557365023?lang=zh_cn&edition=full","pubTime":"2025-08-05 02:22","pubTimestamp":1754331720,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日02时22分，美第奇新星生物技术股票出现波动，股价急速跳水5.24%。截至发稿，该股报1.36美元/股，成交量2.1366万股，换手率0.04%，振幅4.36%。美第奇新星生物技术股票所在的生物技术行业中，整体涨幅为1.43%。美第奇新星生物技术公司简介：MediciNova Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805022201a474e64c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805022201a474e64c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNOV","BK4139"],"gpt_icon":0},{"id":"2517940656","title":"美第奇新星生物技术盘中异动 下午盘大幅上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517940656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517940656?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:07","pubTimestamp":1741198034,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时07分，美第奇新星生物技术股票出现波动，股价快速上涨5.10%。截至发稿，该股报1.65美元/股，成交量2493股，换手率0.01%，振幅6.37%。美第奇新星生物技术股票所在的生物技术行业中，整体涨幅为1.47%。美第奇新星生物技术公司简介：MediciNova Inc 是一家生物制药公司。该公司目前的战略是将其开发活动的重点放在神经系统疾病和纤维化疾病的治疗药物上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306020714a2610330&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306020714a2610330&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNOV","BK4139"],"gpt_icon":0},{"id":"2513296693","title":"美第奇新星生物技术盘中异动 股价大涨7.61%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513296693?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148271,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，美第奇新星生物技术股票出现波动，股价快速拉升7.61%。截至发稿，该股报1.91美元/股，成交量410股，换手率0.00%，振幅0.00%。美第奇新星生物技术股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Osr Holdings, Inc.、Nkgen Biotech, Inc.、Acelyrin, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为69.02%、60.21%、17.19%，振幅较大的相关个股有Osr Holdings, Inc.、Gain Therapeutics, Inc.、Windtree Therapeutics, Inc.，振幅分别为11.30%、10.21%、7.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223112a24eb00a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223112a24eb00a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNOV"],"gpt_icon":0},{"id":"2511201696","title":"美第奇新星生物技术盘中异动 早盘大幅上涨5.88%报1.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511201696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511201696?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:42","pubTimestamp":1739544129,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时42分，美第奇新星生物技术股票出现波动，股价急速上涨5.88%。截至发稿，该股报1.98美元/股，成交量5841股，换手率0.01%，振幅4.28%。美第奇新星生物技术股票所在的生物技术行业中，整体涨幅为0.28%。美第奇新星生物技术公司简介：MediciNova Inc 是一家生物制药公司。该公司目前的战略是将其开发活动的重点放在神经系统疾病和纤维化疾病的治疗药物上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422420998858c42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422420998858c42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNOV"],"gpt_icon":0},{"id":"2508668991","title":"美第奇新星生物技术盘中异动 下午盘股价大跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508668991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508668991?lang=zh_cn&edition=full","pubTime":"2025-02-01 03:43","pubTimestamp":1738352625,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日03时43分，美第奇新星生物技术股票出现波动，股价急速下跌5.85%。截至发稿，该股报1.93美元/股，成交量1.2943万股，换手率0.03%，振幅5.37%。美第奇新星生物技术股票所在的生物技术行业中，整体涨幅为0.63%。美第奇新星生物技术公司简介：MediciNova Inc 是一家生物制药公司。该公司目前的战略是将其开发活动的重点放在神经系统疾病和纤维化疾病的治疗药物上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201034345a2357882&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201034345a2357882&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNOV"],"gpt_icon":0},{"id":"2505905043","title":"美第奇新星生物技术盘中异动 股价大涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505905043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505905043?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:25","pubTimestamp":1737649523,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时25分，美第奇新星生物技术股票出现波动，股价大幅上涨6.08%。截至发稿，该股报1.92美元/股，成交量2988股，换手率0.01%，振幅3.31%。美第奇新星生物技术股票所在的生物技术行业中，整体涨幅为0.44%。美第奇新星生物技术公司简介：MediciNova Inc 是一家生物制药公司。该公司目前的战略是将其开发活动的重点放在神经系统疾病和纤维化疾病的治疗药物上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240025239870d076&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240025239870d076&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNOV"],"gpt_icon":0},{"id":"2503570211","title":"美第奇新星生物技术盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503570211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503570211?lang=zh_cn&edition=full","pubTime":"2025-01-14 23:52","pubTimestamp":1736869944,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日23时52分，美第奇新星生物技术股票出现异动，股价大幅跳水5.03%。截至发稿，该股报1.89美元/股，成交量6632股，换手率0.01%，振幅5.53%。美第奇新星生物技术股票所在的生物技术行业中，整体涨幅为0.07%。美第奇新星生物技术公司简介：MediciNova Inc 是一家生物制药公司。该公司目前的战略是将其开发活动的重点放在神经系统疾病和纤维化疾病的治疗药物上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011423522596038e49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011423522596038e49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNOV"],"gpt_icon":0},{"id":"2501716771","title":"美第奇新星生物技术盘中异动 早盘快速跳水5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501716771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501716771?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:35","pubTimestamp":1736346929,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时35分，美第奇新星生物技术股票出现异动，股价大幅跳水5.71%。截至发稿，该股报1.98美元/股，成交量8740股，换手率0.02%，振幅3.81%。美第奇新星生物技术股票所在的生物技术行业中，整体跌幅为0.05%。美第奇新星生物技术公司简介：MediciNova Inc 是一家生物制药公司。该公司目前的战略是将其开发活动的重点放在神经系统疾病和纤维化疾病的治疗药物上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223529a21a541d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223529a21a541d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNOV"],"gpt_icon":0},{"id":"2495940575","title":"美第奇新星生物技术盘中异动 大幅拉升5.31%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495940575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495940575?lang=zh_cn&edition=full","pubTime":"2024-12-31 01:41","pubTimestamp":1735580499,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日01时41分，美第奇新星生物技术股票出现异动，股价急速拉升5.31%。截至发稿，该股报2.18美元/股，成交量1.1432万股，换手率0.02%，振幅3.38%。美第奇新星生物技术股票所在的生物技术行业中，整体跌幅为1.06%。美第奇新星生物技术公司简介：MediciNova Inc 是一家生物制药公司。该公司目前的战略是将其开发活动的重点放在神经系统疾病和纤维化疾病的治疗药物上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123101413998554e5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123101413998554e5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNOV","BK4139"],"gpt_icon":0},{"id":"2494862883","title":"美第奇新星生物技术盘中异动 快速拉升7.95%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494862883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494862883?lang=zh_cn&edition=full","pubTime":"2024-12-27 22:37","pubTimestamp":1735310221,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日22时37分，美第奇新星生物技术股票出现波动，股价大幅上涨7.95%。截至发稿，该股报2.11美元/股，成交量1512股，换手率0.00%，振幅0.00%。美第奇新星生物技术股票所在的生物技术行业中，整体跌幅为0.21%。美第奇新星生物技术公司简介：MediciNova Inc 是一家生物制药公司。该公司目前的战略是将其开发活动的重点放在神经系统疾病和纤维化疾病的治疗药物上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227223702ab94f34f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227223702ab94f34f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNOV","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medicinova.com","stockEarnings":[{"period":"1week","weight":-0.037},{"period":"1month","weight":0.0759},{"period":"3month","weight":0.0065},{"period":"6month","weight":0.1908},{"period":"1year","weight":-0.1522},{"period":"ytd","weight":0.1908}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.0139},{"period":"6month","weight":0.0588},{"period":"1year","weight":0.1291},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MediciNova, Inc.最初于2000年9月26日在特拉华州注册成立。该公司是一家生物制药公司，专注于开发用于治疗医疗需求未得到满足的严重疾病的新型疗法，并将商业重点放在美国市场。公司目前的战略是集中研发资源推进以下两个核心候选药物：MN-166（伊布地拉斯特，ibudilast）：用于治疗神经系统及其他相关疾病，包括进展型多发性硬化症、肌萎缩侧索硬化症（ALS）、化疗引起的周围神经病变、退行性颈椎脊髓病、胶质母细胞瘤、物质依赖与成瘾（例如甲基苯丙胺依赖），以及急性呼吸窘迫综合征（ARDS）的预防；MN-001（替培鲁司特，tipelukast）：用于治疗纤维化及其他代谢性疾病，例如非酒精性脂肪性肝病（NAFLD）和高甘油三酯血症。","yearOnYearQuotes":[{"month":1,"riseRate":0.65,"avgChangeRate":0.069806},{"month":2,"riseRate":0.45,"avgChangeRate":0.056664},{"month":3,"riseRate":0.315789,"avgChangeRate":-0.017388},{"month":4,"riseRate":0.473684,"avgChangeRate":0.029719},{"month":5,"riseRate":0.473684,"avgChangeRate":-0.048112},{"month":6,"riseRate":0.526316,"avgChangeRate":0.015087},{"month":7,"riseRate":0.421053,"avgChangeRate":0.001616},{"month":8,"riseRate":0.526316,"avgChangeRate":-0.001331},{"month":9,"riseRate":0.473684,"avgChangeRate":0.031749},{"month":10,"riseRate":0.526316,"avgChangeRate":-0.010635},{"month":11,"riseRate":0.421053,"avgChangeRate":-0.012868},{"month":12,"riseRate":0.210526,"avgChangeRate":-0.086281}],"exchange":"NASDAQ","name":"美第奇新星生物技术","nameEN":"MediciNova"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美第奇新星生物技术(MNOV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美第奇新星生物技术(MNOV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美第奇新星生物技术,MNOV,美第奇新星生物技术股票,美第奇新星生物技术股票老虎,美第奇新星生物技术股票老虎国际,美第奇新星生物技术行情,美第奇新星生物技术股票行情,美第奇新星生物技术股价,美第奇新星生物技术股市,美第奇新星生物技术股票价格,美第奇新星生物技术股票交易,美第奇新星生物技术股票购买,美第奇新星生物技术股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美第奇新星生物技术(MNOV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美第奇新星生物技术(MNOV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}